Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS

NCT01343914 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01343914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2011
Enrollment
118 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous non-small cell lung cancer